TSH ≥30 mU/lmU/l may not be necessary for successful 131I remnant ablation after total thyroidectomy in patients with differentiated thyroid cancer

被引:0
|
作者
Shen, Chentian [1 ]
Ju, Nianting [1 ]
机构
[1] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 6, Sch Med, Shanghai, Peoples R China
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
P114
引用
收藏
页数:2
相关论文
共 50 条
  • [1] TSH ≥30 mU/L may not be necessary for successful 131I remnant ablation in patients with differentiated thyroid cancer
    Ju, Nianting
    Hou, Liying
    Song, Hongjun
    Qiu, Zhongling
    Wang, Yang
    Sun, Zhenkui
    Luo, Quanyong
    Shen, Chentian
    EUROPEAN THYROID JOURNAL, 2023, 12 (04)
  • [2] Preablation Stimulated Thyroglobulin/TSH Ratio as a Predictor of Successful I(131)Remnant Ablation in Patients with Differentiated Thyroid Cancer following Total Thyroidectomy
    Hussain, Syed Zubair
    Zaman, Maseeh Uz
    Malik, Sarwar
    Ram, Nanik
    Asghar, Ali
    Rabbani, Unaib
    Aftab, Nida
    Islam, Najmul
    JOURNAL OF THYROID RESEARCH, 2014, 2014
  • [3] Preablation Stimulated Thyroglobulin/TSH Ratio As a Predictor of Successful I131remnant Ablation in Patients with Differentiated Thyroid Cancer Following Total Thyroidectomy
    Hussain, Syed Zubair
    Zaman, Maseeh Uz
    Malik, Sarwar
    Ram, Nanik
    Asghar, Ali
    Rabbani, Unaib
    Aftab, Nida
    Islam, Najmul
    ENDOCRINE REVIEWS, 2014, 35 (03)
  • [4] Determinants of successful ablation and complete remission after total thyroidectomy and 131I therapy of paediatric differentiated thyroid cancer
    Frederik A. Verburg
    Uwe Mäder
    Markus Luster
    Heribert Hänscheid
    Christoph Reiners
    European Journal of Nuclear Medicine and Molecular Imaging, 2015, 42 : 1390 - 1398
  • [5] Determinants of successful ablation and complete remission after total thyroidectomy and 131I therapy of paediatric differentiated thyroid cancer
    Verburg, Frederik A.
    Maeder, Uwe
    Luster, Markus
    Haenscheid, Heribert
    Reiners, Christoph
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 (09) : 1390 - 1398
  • [6] Ablation of thyroid remnant with 30 mCi 131I in thyroid cancer patients prepared with recombinant human TSH
    Rosario, Pedro Weslley
    ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA, 2012, 56 (05) : 338 - 340
  • [7] Ablation of the thyroid remnant and 131I dose in differentiated thyroid cancer
    Doi, SAR
    Woodhouse, NJY
    CLINICAL ENDOCRINOLOGY, 2000, 52 (06) : 765 - 773
  • [8] Large remnant 131I ablation as an alternative to completion/total thyroidectomy in the treatment of well-differentiated thyroid cancer
    Leblanc, G
    Tabah, R
    Liberman, M
    Sampalis, J
    Younan, R
    How, J
    SURGERY, 2004, 136 (06) : 1275 - 1278
  • [9] Fluorodeoxyglucose PET/CT in patients with differentiated thyroid cancer and elevated thyroglobulin after total thyroidectomy and 131I ablation
    Salvatore, B.
    Paone, G.
    Klain, M.
    Storto, G.
    Nicolai, E.
    D'Amico, D.
    Della Morte, A. M.
    Pace, L.
    Salvatore, M.
    QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 52 (01): : 2 - 8
  • [10] Large remnant 131I ablation as an alternative to completion/total thyroidectomy in the treatment of well-differentiated thyroid cancer -: Discussion
    Monchik, JM
    Shaha, AR
    Duh, QY
    Raffaelli, M
    Danto, LA
    Snyder, SK
    Reeve, TS
    LeBlanc
    SURGERY, 2004, 136 (06) : 1278 - 1280